tiprankstipranks
Trending News
More News >
Hims & Hers pact with Novo de-risks 2025 outlook, says Needham
PremiumThe FlyHims & Hers pact with Novo de-risks 2025 outlook, says Needham
3d ago
Hims & Hers price target raised to $26 from $22 at BofA
Premium
The Fly
Hims & Hers price target raised to $26 from $22 at BofA
3d ago
Morning Movers: Hims & Hers skyrockets following obesity pact with Novo Nordisk
Premium
The Fly
Morning Movers: Hims & Hers skyrockets following obesity pact with Novo Nordisk
3d ago
Novo Nordisk price target lowered to $102 from $160 at HSBC
PremiumThe FlyNovo Nordisk price target lowered to $102 from $160 at HSBC
4d ago
Novo Nordisk downgraded to Sell from Buy at DBS Bank
Premium
The Fly
Novo Nordisk downgraded to Sell from Buy at DBS Bank
8d ago
Novo Nordisk downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
Novo Nordisk downgraded to Market Perform from Outperform at BMO Capital
8d ago
Eli Lilly selloff on Novo report more than warranted, says Citi
PremiumThe FlyEli Lilly selloff on Novo report more than warranted, says Citi
10d ago
Novo submits obesity pill for FDA approval, BioPharma Dive reports
Premium
The Fly
Novo submits obesity pill for FDA approval, BioPharma Dive reports
11d ago
Novo Nordisk Faces Stock Dip Amidst Market Challenges
Premium
Weekend Updates
Novo Nordisk Faces Stock Dip Amidst Market Challenges
13d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100